Phillip B. Storm, M.D., is the Leslie N. Sutton Professor and Chief of the Division of Neurosurgery at the Children’s Hospital of Philadelphia (CHOP) and the Director of the Center for Data-Driven Discovery in Biomedicine (D3b). He earned his medical degree from the Johns Hopkins University School of Medicine, where he was inducted into the Alpha Omega Alpha (AOA) Honor Medical Society. Dr. Storm completed his residency in neurological surgery and a fellowship in neuro-oncology research at Johns Hopkins Hospital, followed by a pediatric neurosurgery fellowship at CHOP in 2003. He joined the faculty at CHOP and the University of Pennsylvania in 2004.
An internationally recognized pediatric neurosurgeon, Dr. Storm specializes in brain and spine tumors and is a leader in endoscopic skull base surgery. His pioneering techniques have improved surgical outcomes while minimizing morbidity. Beyond his clinical expertise, Dr. Storm has played a transformative role in pediatric brain tumor research. Under his leadership, the Children’s Brain Tumor Network (CBTN) expanded from a four-hospital collaboration to a 35-institution international consortium committed to real-time, open-data sharing.
In 2016, Dr. Storm co-founded the Center for Data-Driven Discovery in Biomedicine (D3b) with Adam Resnick, Ph.D., launching CAVATICA, a cloud-based biomedical data analysis platform. Originally part of the White House Precision Medicine Initiative, CAVATICA enables researchers to access, analyze, and share pediatric disease data on a global scale. D3b has since developed a robust ecosystem integrating multi-omics data, advanced imaging, and patient outcomes to drive novel therapeutic discoveries. Through these initiatives, Dr. Storm has helped secure over $250 million in NIH, ARPA-H, and philanthropic funding, advancing pediatric brain tumor research across the lifespan.
His research has been published in Cell, Science, The New England Journal of Medicine, and Nature Genetics. His dedication to innovation and collaboration continues to shape the future of neurosurgery and pediatric cancer research.